Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according to ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...